The relation between clinical phenotypes, gold groups/stages and mortality in copd patients – a prospective multicenter study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F21%3AA2202DF0" target="_blank" >RIV/61988987:17110/21:A2202DF0 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00843989:_____/21:E0108978
Výsledek na webu
<a href="https://www.dovepress.com/getfile.php?fileID=68876" target="_blank" >https://www.dovepress.com/getfile.php?fileID=68876</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2147/COPD.S297087" target="_blank" >10.2147/COPD.S297087</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The relation between clinical phenotypes, gold groups/stages and mortality in copd patients – a prospective multicenter study
Popis výsledku v původním jazyce
Introduction: The concept of phenotyping emerged, reflecting specific clinical, pulmonary and extrapulmonary features of each particular chronic obstructive pulmonary disease (COPD) case. Our aim was to analyze prognostic utility of: “Czech“ COPD phenotypes and their most frequent combinations, ”Spanish” phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages + groups in relation to long-term mortality risk. Methods: Data were extracted from the Czech Multicenter Research Database (CMRD) of COPD. Kaplan-Meier (KM) estimates (at 60 months from inclusion) were used for mortality assessment. Survival rates were calculated for the six elementary “Czech” phenotypes and their most frequent and relevant combinations, “Spanish” phenotypes, GOLD grades and groups. Statistically significant differences were tested by Log Rank test. An analysis of factors underlying mortality risk (the role of confounders) has been assessed with the use of classification and regression tree (CART) analysis. Basic factors showing significant differences between deceased and living patients were entered into the CART model. This showed six different risk groups, the differences in risk were tested by a Log Rank test. Results: The cohort (n=720) was 73.1% men, with a mean age of 66.6 years and mean FEV1 44.4% pred.
Název v anglickém jazyce
The relation between clinical phenotypes, gold groups/stages and mortality in copd patients – a prospective multicenter study
Popis výsledku anglicky
Introduction: The concept of phenotyping emerged, reflecting specific clinical, pulmonary and extrapulmonary features of each particular chronic obstructive pulmonary disease (COPD) case. Our aim was to analyze prognostic utility of: “Czech“ COPD phenotypes and their most frequent combinations, ”Spanish” phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages + groups in relation to long-term mortality risk. Methods: Data were extracted from the Czech Multicenter Research Database (CMRD) of COPD. Kaplan-Meier (KM) estimates (at 60 months from inclusion) were used for mortality assessment. Survival rates were calculated for the six elementary “Czech” phenotypes and their most frequent and relevant combinations, “Spanish” phenotypes, GOLD grades and groups. Statistically significant differences were tested by Log Rank test. An analysis of factors underlying mortality risk (the role of confounders) has been assessed with the use of classification and regression tree (CART) analysis. Basic factors showing significant differences between deceased and living patients were entered into the CART model. This showed six different risk groups, the differences in risk were tested by a Log Rank test. Results: The cohort (n=720) was 73.1% men, with a mean age of 66.6 years and mean FEV1 44.4% pred.
Klasifikace
Druh
J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS
CEP obor
—
OECD FORD obor
30218 - General and internal medicine
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of COPD
ISSN
1176-9106
e-ISSN
—
Svazek periodika
16
Číslo periodika v rámci svazku
2021
Stát vydavatele periodika
NZ - Nový Zéland
Počet stran výsledku
11
Strana od-do
1171-1182
Kód UT WoS článku
—
EID výsledku v databázi Scopus
2-s2.0-85105466703